ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,428, issued on May 13, was assigned to Yale University (New Haven, Conn.).
"Compositions for identification of membrane targets for enhancement of T cell activity against cancer" was invented by Sidi Chen (Milford, Conn.), Lupeng Ye (New Haven, Conn.), Jonathan Park (Scott AFB, Ill.), Matthew Dong (San Francisco) and Ryan D. Chow (San Jose, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes compositions and methods for identification of membrane targets for enhancement of T cell activity against a disease, disorder or condition, and/or enhancing T cell anti-tumor activity in a subject in need thereof. In some embodi...